KRISTEN DECELLI: Open Payments
NPI 1780160549 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,008 in 96 payments from 19 companies in 2025. Trend: 2023 $826 · 2024 $1,303 · 2025 $2,008
Food & beverage: $2,008
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 35 | $593 |
| Antares Pharma, Inc. | 17 | $261 |
| Janssen Biotech, Inc. | 4 | $145 |
| Ferring Pharmaceuticals Inc. | 5 | $139 |
| ABBVIE INC. | 5 | $114 |
| Boston Scientific Corporation | 1 | $101 |
| Merck Sharp & Dohme LLC | 4 | $99 |
| Endo USA, Inc. | 5 | $95 |
| Astellas Pharma US Inc | 3 | $82 |
| Olympus America Inc. | 3 | $69 |
Products named: GEMTESA, XYOSTED, ADSTILADRIN, Xtandi, ERLEADA, AMS 700, AVEED, KEYTRUDA.
Industry payments across NY — which companies pay providers there.
